Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 21.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 269,774 shares of the company’s stock after selling 74,823 shares during the quarter. Victory Capital Management Inc.’s holdings in Acadia Healthcare were worth $20,978,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Headlands Technologies LLC purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at about $25,000. GAMMA Investing LLC acquired a new stake in Acadia Healthcare in the fourth quarter valued at approximately $26,000. Fifth Third Bancorp raised its stake in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the period. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter worth $96,000. Finally, Oak Thistle LLC acquired a new stake in Acadia Healthcare during the 4th quarter valued at $235,000.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.00% of the stock is owned by company insiders.

Acadia Healthcare Trading Up 6.7 %

Acadia Healthcare stock opened at $70.49 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. Acadia Healthcare Company, Inc. has a 1 year low of $64.74 and a 1 year high of $87.77. The firm’s 50-day moving average is $75.41 and its 200-day moving average is $77.27. The company has a market cap of $6.54 billion, a P/E ratio of -503.50, a PEG ratio of 1.96 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. Acadia Healthcare’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.75 earnings per share. On average, equities analysts expect that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ACHC shares. Bank of America cut their price objective on shares of Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Barclays reduced their price target on Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday, May 2nd. TD Cowen lifted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.89.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.